SlideShare a Scribd company logo
PhyNexus                                              Technical Note                                       www.phynexus.com




           PhyTip® 5K Gel Filtration column for
       automated high throughput desalting & buffer
             exchange of functional proteins


       High Performance:
       ●  Remove >95% of salts with >80% yield of protein
       ●  Retain protein functionality
       ●  <10% CV in volume and concentration
       ●  Ready for downstream assay
       Automated desalting/buffer exchange of functional proteins:
       ●  Fully automated process with MEA Personal Purification System
       ●  12 samples desalted/buffer exchanged in ~30 minutes.
       High throughput format:
       ●  Available in 96 sample format for high throughput processing


Introduction

For biopharmaceutical companies whose focus is                                   preparing large numbers of potential leads that
on antibody and recombinant protein molecules,                                   are ready for functional assays without the need
there is an increasing desire to perform more                                    for scale-up.
screens of potential leads where the data
generated are more physiologically relevant to the                               In many cases differing elution conditions are
issues of potency, toxicity, and other factors.                                  required for various downstream functional
These assay formats all require that the antibodies                              assays. Furthermore, the final purification
and recombinant proteins are well purified,                                      product may require an additional preparation
enriched and functional. By utilizing high-                                      step to either reduce toxic buffer salts or to
performance micro scale functional protein                                       completely exchange buffer conditions. This
separations, it is now possible to obtain more                                   latter step can now be achieved through fully
physiologically relevant data at the high-content                                automated desalting and buffer exchange with
screening step and thus make the decision-making                                 PhyTip 5K gel filtration columns used in
power available at the earliest stages in the                                    conjunction with the MEA Personal Purification
discovery process. PhyNexus PhyTip column                                        System. These unique columns allow for high
technology has been developed for high-                                          recovery of the functional antibody of interest
throughput preparation of antibodies and                                         while removing greater than 95% of salts.
recombinant proteins to facilitate the process of




For further support call PhyNexus at 408.267.7214 or e-mail support@phynexus.com.
For further information on PhyNexus products visit our website at www.phynexus.com            Copyright © 2008, PhyNexus, Inc., All Rights Reserved
PhyNexus PhyTip 5K Gel Filtration                                                                                            Technical Note
                          Fig 1 PhyTip 5K Gel Filtration Columns
                                       The design of the patent pending 5K gel filtration columns (Fig 1) is based
                                       upon a unique manufacturing process where pipette tips are filled with gel
                                       filtration resin. Thin screens are placed above and below the resin bed that
                                       retain the gel filtration media within the column structure, while allowing the
                                       passage of liquids. The top frit is a larger liquid interface barrier that helps
                                       facilitate the transfer of liquid to the top of the column. PhyTip 5K gel
                                       filtration columns retain small molecules while molecules over 5 KDa will
                                       pass through the gel filtration media.
                          screens
                                       Desalting or Buffer Exchange Process
                                       Using the MEA Personal Purification System, a row of either 200µL or
Resin bed
resin bed PhyTip 5K gel filtration columns are conditioned in 1mL of buffer. After the columns are
conditioned, samples are added and processed followed by differing volumes of chaser buffer addition
and processing. The samples can be collected in fractions to determine the optimal sample recovery
and salt removal conditions. Using the MEA Personal Purification System, each row of 12 samples
requires 30 minutes to process while the entire plate of 96 samples can be processed in 2.5 hours.

Results
The process of desalting or buffer exchange using the PhyTip 5K desalting columns and the MEA
Personal Purification System have been carefully optimized to ensure both maximum recovery of the
protein of interest and removal of salt.
                                                                                     160                                                                 Fig 2A
                                                                                     140

Consistent Volume Recovery                                                           120
                                                                                                                                                           Exp 1
                                                                               vol in uL




Most pharmaceutical companies streamline the
                                                                                     100

                                                                                           80                                                              Exp 2
processes of antibody/protein production,                                                  60
                                                                                                                                                           Exp 3
purification, and desalting/buffer exchange for                                            40


cell-based assays. In order to efficiently process                                         20

                                                                                           0
the samples from production to cell-based assays,                                               1   2   3   4    5   6   7   8   9   10   11   12

high throughput solutions are desirable.                                                                        PhyTip columns
However, in practice, achieving a true high
throughput solution requires a level of precision
                                                                                                                                                        Fig 2B
                                                                              Chaser Vol                    E1: (80uL) E2: (80uL) E3: (130uL)
not easily achieved. High throughput sample                                   Column1                         73.4       70.9        122.6
preparation is not advantageous if subsequent                                 Column2                         71.4       77.4        132.6
quantification is required prior to the next assay.                           Column3                         65.9       64.4        112.6
The solution requires consistent mass and                                     Column4                         61.8       65.2        115.0
concentration recovery.                                                       Column5                         61.6       73.8        118.8
                                                                              Column6                         61.9       61.6        106.5
To determine the consistency of volume                                        Column7                         60.0       73.6        119.4
                                                                              Column8                         71.4       76.7        120.6
recovery from 200µL resin bed PhyTip gel
                                                                              Column9                         67.1       72.6        133.4
filtration columns, 80µL or 130µL of buffer was                               Column10                        61.6       71.6        121.0
loaded on top of 11 or 12 conditioned columns.                                Column11                        64.7       70.7        110.0
Flow through was collected and the volume was                                 Column12                        65.4       74.9
measured. In three replicate experiments,                                     Average                         65.5       71.1        119.3
recovered volumes varied by less than 10% CV                                  SD                                4.5        5.0         8.4
(Fig 2A & 2B).                                                                CV                                6.9        7.0         7.0




For further support call PhyNexus at 408.267.7214 or e-mail support@phynexus.com.
For further information on PhyNexus products visit our website at www.phynexus.com                              Copyright © 2008, PhyNexus, Inc., All Rights Reserved
PhyNexus PhyTip 5K Gel Filtration                                                                             Technical Note
Separation by PhyTip gel filtration column                                                                                                            Fig 3
Sample (far left microfuge tube) containing brown
myoglobin protein (16.7kDa) and yellow DNP-                                                      1      2        3       4       5    6         7
                                                                                         1
glutamate salt (313Da) was loaded onto a 600uL
PhyTip gel filtration column. The same PhyTip column
at different steps of desalting is pictured along with
the collected flow through. From left: 1) column
conditioned by PBS buffer prior to sample loading, 2)
column after 200µL sample has entered the resin bed,
3-6) column after 100µL PBS buffer is applied, 7)
column after a final chase of 400uL PBS buffer. This
example illustrates a typical separation allowing the                                                   2      3         4       5     6         7
user to discard sample flow through (2) to maintain
concentrated purifications. Additionally, salt is
retained until fraction (6), while most of the protein is
released by fraction (4).


HPLC chromatogram (at right) of His-Tagged                                                                       Sample
                                                                                                              Pre-Desalting
                                                                                                                                                      Fig 4
ubiquitin at 0.05mg/mL concentration spiked with
250mM imidazole. 300µL samples (red) were applied
to 600µL columns. The resulting desalted sample was                                                                                   His-Ubiquitin

collected and adjusted to 300µL with water (blue) to
compare with the starting sample. Water was injected
as a blank (green). The Post-desalting sample shows                                                        Sample

both recovery of protein and complete removal of
                                                                                                        Post-Desalting



imidazole.                                                                                                                    Blank




Myoglobin recovery and salt removal
After columns are conditioned, samples are first added and processed followed by different volumes of
chaser buffer addition and processing. The samples can be collected in fractions to determine the
maximum sample recovery. In this experiment, we used myoglobin and DNP-glutamate (20µL sample
volume) and separated myoglobin from DNP-glutamate using 80µL chaser volume (Table 1) and 200µL
resin bed gel filtration columns. As shown in the table below, we were able to recover ~80% of
myoglobin and remove ~99.8% of DNP-glutamate. Using the MEA Personal Purification System each
row of 12 samples can be separated in about 30 minutes. A full plate of 96 samples takes about 2.5
hours to process.

 Table 1:
                                       A364 A409              Volume          pmol Myo       mol Salt        % prot rec                    %salt rem
  Myoglobin input                           1.165             20.0            47843.9
  Myoglobin sample1                         0.205             90.5            38095.5                                    79.6
  Myoglobin sample2                         0.200             94.8            38932.2                                    81.4

  DNP-glutamate input   2.440                                 20.0                           70469.3
  DNP-glutamate sample1 0.003                                 88.7                           96.1                                               99.9
  DNP-glutamate sample2 0.006                                 89.3                           193.4                                              99.7




For further support call PhyNexus at 408.267.7214 or e-mail support@phynexus.com.
For further information on PhyNexus products visit our website at www.phynexus.com             Copyright © 2008, PhyNexus, Inc., All Rights Reserved
PhyNexus PhyTip 5K Gel Filtration                                                                                   Technical Note
                                                                                 uL/% recov                                       mg/mL         Fig 5
IgG separation and recovery                                                          140


IgG was separated from free dye using a 200µL                                        120                                           1.2


resin bed gel filtration column. In this experiment,                                 100                                           1.0
                                                                                                                                             Vol Rec ( uL)
PhyTip gel filtration columns were first conditioned                                 80
                                                                                                                                             Conc [ mg/ mL]

with 800µL of PBS. After conditioning, 40µL of                                       60                                                      %IgG r ec


[2mg/mL] sample was added and processed                                              40                                            0.4


followed by 130µL of chaser (PBS) buffer to the                                      20                                            0.2


PhyTip gel filtration column to collect and separate                                  0
                                                                                           1      2      3      4      5      6
IgG from unlabeled dyes.



Figure 5 and Table 2 demonstrate that we were able to recover an average of 76% of IgG (Table 2, Fig.
5 red) with an average of 0.5mg/mL concentration (Table 2, Fig. 5 blue) in an average final volume of
121µL (table 2, fig 5 black). As shown in Table 2, the percent IgG recovery, concentration, and final
recovered volume had very small CV values. These SD and CV values show the reliability and
consistency of the PhyTip gel filtration columns.


  Table 2
                  Column           Final Volume                 Concentration                  Mass Recovered                  % Protein
                       #                [µL]                      [mg/mL]                           (mg)                       Recovered
                       1                122                         0.49                           0.060                          75
                       2                119                         0.50                           0.060                          74
                       3                122                         0.50                           0.061                          76
                       4                119                         0.54                           0.064                          80
                       5                122                         0.48                           0.059                          73
                       6                123                         0.51                           0.063                          78
                     Ave                121                         0.50                           0.061                          76
                      SD                  2                         0.02                           0.002                           3
                      CV                 1.4                        4.1                              3.5                           4


Conclusion
PhyTip 5K gel filtration columns and the MEA Personal Purification System represent a high throughput
solution for rapid desalting and buffer exchange. PhyTip 5K gel filtration columns can process 12
samples in 30 minutes compared to the laborious and time consuming dialysis procedure. Using PhyTip
5K gel filtration columns, researchers can save hours while obtaining a high level of performance.
Unlike spin columns, PhyTip columns simulate traditional chromatography and can perform
fractionation of protein samples. This allows researchers to optimize maximum protein recovery and
salt removal in an automated, high throughput manner.

PhyTip 5K gel filtration columns can be used in combination with PhyTip purification columns on the
MEA Personal Purification System. This allows researchers to combine purification with desalting and
buffer exchange. For example, 6-His-tagged proteins can be purified by PhyNexus IMAC PhyTip
columns and eluted using high concentrations of imidazole, which can be removed by PhyTip gel
filtration columns. These processes allow researchers to perform multiple sample processing steps in a
high throughput, walk-away scenario.



For further support call PhyNexus at 408.267.7214 or e-mail support@phynexus.com.
For further information on PhyNexus products visit our website at www.phynexus.com                    Copyright © 2008, PhyNexus, Inc., All Rights Reserved

More Related Content

What's hot

Long acting injectable microparticle formulation - a new dimension for peptid...
Long acting injectable microparticle formulation - a new dimension for peptid...Long acting injectable microparticle formulation - a new dimension for peptid...
Long acting injectable microparticle formulation - a new dimension for peptid...
Merck Life Sciences
 
Internship presentation 9 23merge
Internship presentation 9 23mergeInternship presentation 9 23merge
Internship presentation 9 23mergeMarcia Coffey
 
Frozen Cells For Corning Epic Label Free App
Frozen Cells For Corning Epic Label Free AppFrozen Cells For Corning Epic Label Free App
Frozen Cells For Corning Epic Label Free App
alan_williams
 
Exploring Intensified Seed Train Through Advancements in Perfusion Processing...
Exploring Intensified Seed Train Through Advancements in Perfusion Processing...Exploring Intensified Seed Train Through Advancements in Perfusion Processing...
Exploring Intensified Seed Train Through Advancements in Perfusion Processing...
Merck Life Sciences
 
HIV Vaccines Process Development & Manufacturing - Pitfalls & Possibilities
HIV Vaccines Process Development & Manufacturing - Pitfalls & PossibilitiesHIV Vaccines Process Development & Manufacturing - Pitfalls & Possibilities
HIV Vaccines Process Development & Manufacturing - Pitfalls & Possibilities
KBI Biopharma
 

What's hot (6)

Long acting injectable microparticle formulation - a new dimension for peptid...
Long acting injectable microparticle formulation - a new dimension for peptid...Long acting injectable microparticle formulation - a new dimension for peptid...
Long acting injectable microparticle formulation - a new dimension for peptid...
 
Internship presentation 9 23merge
Internship presentation 9 23mergeInternship presentation 9 23merge
Internship presentation 9 23merge
 
Frozen Cells For Corning Epic Label Free App
Frozen Cells For Corning Epic Label Free AppFrozen Cells For Corning Epic Label Free App
Frozen Cells For Corning Epic Label Free App
 
Stimuli PF 40 6 final
Stimuli PF 40 6 finalStimuli PF 40 6 final
Stimuli PF 40 6 final
 
Exploring Intensified Seed Train Through Advancements in Perfusion Processing...
Exploring Intensified Seed Train Through Advancements in Perfusion Processing...Exploring Intensified Seed Train Through Advancements in Perfusion Processing...
Exploring Intensified Seed Train Through Advancements in Perfusion Processing...
 
HIV Vaccines Process Development & Manufacturing - Pitfalls & Possibilities
HIV Vaccines Process Development & Manufacturing - Pitfalls & PossibilitiesHIV Vaccines Process Development & Manufacturing - Pitfalls & Possibilities
HIV Vaccines Process Development & Manufacturing - Pitfalls & Possibilities
 

Similar to PhyNexus Desalting Columns

Automated Protein Purification Process Development on Caliper LifeSciences Sy...
Automated Protein Purification Process Development on Caliper LifeSciences Sy...Automated Protein Purification Process Development on Caliper LifeSciences Sy...
Automated Protein Purification Process Development on Caliper LifeSciences Sy...Chris Suh
 
BioInnovation Leader Summit Transforming Process Efficiency
 BioInnovation Leader Summit Transforming Process Efficiency BioInnovation Leader Summit Transforming Process Efficiency
BioInnovation Leader Summit Transforming Process Efficiency
GBX Summits
 
Dr. Elke Prohaska & Regina Römling BioInnovation Leader Summit Tosoh
Dr. Elke Prohaska & Regina Römling BioInnovation Leader Summit TosohDr. Elke Prohaska & Regina Römling BioInnovation Leader Summit Tosoh
Dr. Elke Prohaska & Regina Römling BioInnovation Leader Summit Tosoh
GBX Summits
 
The MEA 2 Personal Purification System for enhanced automated protein purific...
The MEA 2 Personal Purification System for enhanced automated protein purific...The MEA 2 Personal Purification System for enhanced automated protein purific...
The MEA 2 Personal Purification System for enhanced automated protein purific...
Anne Burke
 
More on simulated moving bed chromatography
More on simulated moving bed chromatographyMore on simulated moving bed chromatography
More on simulated moving bed chromatography
Hossein Hodjat
 
Scale up quickly and reliably with TFF Pelicon cassettes
Scale up quickly and reliably with TFF Pelicon cassettesScale up quickly and reliably with TFF Pelicon cassettes
Scale up quickly and reliably with TFF Pelicon cassettes
Frédéric Sengler
 
BAC BV resins in PhyTip columns for Protein Purification
BAC BV resins in PhyTip columns for Protein PurificationBAC BV resins in PhyTip columns for Protein Purification
BAC BV resins in PhyTip columns for Protein Purification
Chris Suh
 
High Throughput Purification and Characterization of a Protein Variant Library
High Throughput Purification and Characterization of a Protein Variant LibraryHigh Throughput Purification and Characterization of a Protein Variant Library
High Throughput Purification and Characterization of a Protein Variant Library
Chris Suh
 
Scalability of Cell Culture Processes in Single-use Bioreactors using Differe...
Scalability of Cell Culture Processes in Single-use Bioreactors using Differe...Scalability of Cell Culture Processes in Single-use Bioreactors using Differe...
Scalability of Cell Culture Processes in Single-use Bioreactors using Differe...
KBI Biopharma
 
parasite DNA extraction .pptx
parasite DNA extraction .pptxparasite DNA extraction .pptx
parasite DNA extraction .pptx
University of Maiduguri
 
Pepsi bio link
Pepsi bio linkPepsi bio link
Pepsi bio link
bio-link
 
Protein Purification and Analysis with PhyNexus and Caliper LifeSciences
Protein Purification and Analysis with PhyNexus and Caliper LifeSciencesProtein Purification and Analysis with PhyNexus and Caliper LifeSciences
Protein Purification and Analysis with PhyNexus and Caliper LifeSciences
Chris Suh
 
Nutrichip
NutrichipNutrichip
Nutrichip
dalgetty
 
Platforms for mAb Commercialization
Platforms for mAb Commercialization Platforms for mAb Commercialization
Platforms for mAb Commercialization
KBI Biopharma
 
Development of chemoenzymatic process.pptx
Development of chemoenzymatic process.pptxDevelopment of chemoenzymatic process.pptx
Development of chemoenzymatic process.pptx
rajeshkumar590473
 
High Throughput Bioreactor Mimetic in Early and Late Stage Process Development
High Throughput Bioreactor Mimetic in Early and Late Stage Process DevelopmentHigh Throughput Bioreactor Mimetic in Early and Late Stage Process Development
High Throughput Bioreactor Mimetic in Early and Late Stage Process Development
KBI Biopharma
 
09 CeoMeeting- Session2- Mascoma
09 CeoMeeting- Session2- Mascoma09 CeoMeeting- Session2- Mascoma
09 CeoMeeting- Session2- Mascoma
MLSCF
 
Webinar: Novel Perfusion Filter and Controller for N-1 Application
Webinar: Novel Perfusion Filter and Controller for N-1 ApplicationWebinar: Novel Perfusion Filter and Controller for N-1 Application
Webinar: Novel Perfusion Filter and Controller for N-1 Application
Merck Life Sciences
 
Webinar: Novel Perfusion Filter and Controller for N-1 Application
Webinar: Novel Perfusion Filter and Controller for N-1 ApplicationWebinar: Novel Perfusion Filter and Controller for N-1 Application
Webinar: Novel Perfusion Filter and Controller for N-1 Application
MilliporeSigma
 

Similar to PhyNexus Desalting Columns (20)

Automated Protein Purification Process Development on Caliper LifeSciences Sy...
Automated Protein Purification Process Development on Caliper LifeSciences Sy...Automated Protein Purification Process Development on Caliper LifeSciences Sy...
Automated Protein Purification Process Development on Caliper LifeSciences Sy...
 
BioInnovation Leader Summit Transforming Process Efficiency
 BioInnovation Leader Summit Transforming Process Efficiency BioInnovation Leader Summit Transforming Process Efficiency
BioInnovation Leader Summit Transforming Process Efficiency
 
Dr. Elke Prohaska & Regina Römling BioInnovation Leader Summit Tosoh
Dr. Elke Prohaska & Regina Römling BioInnovation Leader Summit TosohDr. Elke Prohaska & Regina Römling BioInnovation Leader Summit Tosoh
Dr. Elke Prohaska & Regina Römling BioInnovation Leader Summit Tosoh
 
The MEA 2 Personal Purification System for enhanced automated protein purific...
The MEA 2 Personal Purification System for enhanced automated protein purific...The MEA 2 Personal Purification System for enhanced automated protein purific...
The MEA 2 Personal Purification System for enhanced automated protein purific...
 
More on simulated moving bed chromatography
More on simulated moving bed chromatographyMore on simulated moving bed chromatography
More on simulated moving bed chromatography
 
Scale up quickly and reliably with TFF Pelicon cassettes
Scale up quickly and reliably with TFF Pelicon cassettesScale up quickly and reliably with TFF Pelicon cassettes
Scale up quickly and reliably with TFF Pelicon cassettes
 
BAC BV resins in PhyTip columns for Protein Purification
BAC BV resins in PhyTip columns for Protein PurificationBAC BV resins in PhyTip columns for Protein Purification
BAC BV resins in PhyTip columns for Protein Purification
 
High Throughput Purification and Characterization of a Protein Variant Library
High Throughput Purification and Characterization of a Protein Variant LibraryHigh Throughput Purification and Characterization of a Protein Variant Library
High Throughput Purification and Characterization of a Protein Variant Library
 
High-performing CHO cell lines
High-performing CHO cell lines High-performing CHO cell lines
High-performing CHO cell lines
 
Scalability of Cell Culture Processes in Single-use Bioreactors using Differe...
Scalability of Cell Culture Processes in Single-use Bioreactors using Differe...Scalability of Cell Culture Processes in Single-use Bioreactors using Differe...
Scalability of Cell Culture Processes in Single-use Bioreactors using Differe...
 
parasite DNA extraction .pptx
parasite DNA extraction .pptxparasite DNA extraction .pptx
parasite DNA extraction .pptx
 
Pepsi bio link
Pepsi bio linkPepsi bio link
Pepsi bio link
 
Protein Purification and Analysis with PhyNexus and Caliper LifeSciences
Protein Purification and Analysis with PhyNexus and Caliper LifeSciencesProtein Purification and Analysis with PhyNexus and Caliper LifeSciences
Protein Purification and Analysis with PhyNexus and Caliper LifeSciences
 
Nutrichip
NutrichipNutrichip
Nutrichip
 
Platforms for mAb Commercialization
Platforms for mAb Commercialization Platforms for mAb Commercialization
Platforms for mAb Commercialization
 
Development of chemoenzymatic process.pptx
Development of chemoenzymatic process.pptxDevelopment of chemoenzymatic process.pptx
Development of chemoenzymatic process.pptx
 
High Throughput Bioreactor Mimetic in Early and Late Stage Process Development
High Throughput Bioreactor Mimetic in Early and Late Stage Process DevelopmentHigh Throughput Bioreactor Mimetic in Early and Late Stage Process Development
High Throughput Bioreactor Mimetic in Early and Late Stage Process Development
 
09 CeoMeeting- Session2- Mascoma
09 CeoMeeting- Session2- Mascoma09 CeoMeeting- Session2- Mascoma
09 CeoMeeting- Session2- Mascoma
 
Webinar: Novel Perfusion Filter and Controller for N-1 Application
Webinar: Novel Perfusion Filter and Controller for N-1 ApplicationWebinar: Novel Perfusion Filter and Controller for N-1 Application
Webinar: Novel Perfusion Filter and Controller for N-1 Application
 
Webinar: Novel Perfusion Filter and Controller for N-1 Application
Webinar: Novel Perfusion Filter and Controller for N-1 ApplicationWebinar: Novel Perfusion Filter and Controller for N-1 Application
Webinar: Novel Perfusion Filter and Controller for N-1 Application
 

Recently uploaded

FIDO Alliance Osaka Seminar: Overview.pdf
FIDO Alliance Osaka Seminar: Overview.pdfFIDO Alliance Osaka Seminar: Overview.pdf
FIDO Alliance Osaka Seminar: Overview.pdf
FIDO Alliance
 
UiPath Test Automation using UiPath Test Suite series, part 4
UiPath Test Automation using UiPath Test Suite series, part 4UiPath Test Automation using UiPath Test Suite series, part 4
UiPath Test Automation using UiPath Test Suite series, part 4
DianaGray10
 
Generating a custom Ruby SDK for your web service or Rails API using Smithy
Generating a custom Ruby SDK for your web service or Rails API using SmithyGenerating a custom Ruby SDK for your web service or Rails API using Smithy
Generating a custom Ruby SDK for your web service or Rails API using Smithy
g2nightmarescribd
 
Key Trends Shaping the Future of Infrastructure.pdf
Key Trends Shaping the Future of Infrastructure.pdfKey Trends Shaping the Future of Infrastructure.pdf
Key Trends Shaping the Future of Infrastructure.pdf
Cheryl Hung
 
Elevating Tactical DDD Patterns Through Object Calisthenics
Elevating Tactical DDD Patterns Through Object CalisthenicsElevating Tactical DDD Patterns Through Object Calisthenics
Elevating Tactical DDD Patterns Through Object Calisthenics
Dorra BARTAGUIZ
 
Encryption in Microsoft 365 - ExpertsLive Netherlands 2024
Encryption in Microsoft 365 - ExpertsLive Netherlands 2024Encryption in Microsoft 365 - ExpertsLive Netherlands 2024
Encryption in Microsoft 365 - ExpertsLive Netherlands 2024
Albert Hoitingh
 
Leading Change strategies and insights for effective change management pdf 1.pdf
Leading Change strategies and insights for effective change management pdf 1.pdfLeading Change strategies and insights for effective change management pdf 1.pdf
Leading Change strategies and insights for effective change management pdf 1.pdf
OnBoard
 
FIDO Alliance Osaka Seminar: Passkeys at Amazon.pdf
FIDO Alliance Osaka Seminar: Passkeys at Amazon.pdfFIDO Alliance Osaka Seminar: Passkeys at Amazon.pdf
FIDO Alliance Osaka Seminar: Passkeys at Amazon.pdf
FIDO Alliance
 
PCI PIN Basics Webinar from the Controlcase Team
PCI PIN Basics Webinar from the Controlcase TeamPCI PIN Basics Webinar from the Controlcase Team
PCI PIN Basics Webinar from the Controlcase Team
ControlCase
 
State of ICS and IoT Cyber Threat Landscape Report 2024 preview
State of ICS and IoT Cyber Threat Landscape Report 2024 previewState of ICS and IoT Cyber Threat Landscape Report 2024 preview
State of ICS and IoT Cyber Threat Landscape Report 2024 preview
Prayukth K V
 
GenAISummit 2024 May 28 Sri Ambati Keynote: AGI Belongs to The Community in O...
GenAISummit 2024 May 28 Sri Ambati Keynote: AGI Belongs to The Community in O...GenAISummit 2024 May 28 Sri Ambati Keynote: AGI Belongs to The Community in O...
GenAISummit 2024 May 28 Sri Ambati Keynote: AGI Belongs to The Community in O...
Sri Ambati
 
Mission to Decommission: Importance of Decommissioning Products to Increase E...
Mission to Decommission: Importance of Decommissioning Products to Increase E...Mission to Decommission: Importance of Decommissioning Products to Increase E...
Mission to Decommission: Importance of Decommissioning Products to Increase E...
Product School
 
UiPath Test Automation using UiPath Test Suite series, part 3
UiPath Test Automation using UiPath Test Suite series, part 3UiPath Test Automation using UiPath Test Suite series, part 3
UiPath Test Automation using UiPath Test Suite series, part 3
DianaGray10
 
AI for Every Business: Unlocking Your Product's Universal Potential by VP of ...
AI for Every Business: Unlocking Your Product's Universal Potential by VP of ...AI for Every Business: Unlocking Your Product's Universal Potential by VP of ...
AI for Every Business: Unlocking Your Product's Universal Potential by VP of ...
Product School
 
FIDO Alliance Osaka Seminar: Passkeys and the Road Ahead.pdf
FIDO Alliance Osaka Seminar: Passkeys and the Road Ahead.pdfFIDO Alliance Osaka Seminar: Passkeys and the Road Ahead.pdf
FIDO Alliance Osaka Seminar: Passkeys and the Road Ahead.pdf
FIDO Alliance
 
Accelerate your Kubernetes clusters with Varnish Caching
Accelerate your Kubernetes clusters with Varnish CachingAccelerate your Kubernetes clusters with Varnish Caching
Accelerate your Kubernetes clusters with Varnish Caching
Thijs Feryn
 
From Siloed Products to Connected Ecosystem: Building a Sustainable and Scala...
From Siloed Products to Connected Ecosystem: Building a Sustainable and Scala...From Siloed Products to Connected Ecosystem: Building a Sustainable and Scala...
From Siloed Products to Connected Ecosystem: Building a Sustainable and Scala...
Product School
 
Empowering NextGen Mobility via Large Action Model Infrastructure (LAMI): pav...
Empowering NextGen Mobility via Large Action Model Infrastructure (LAMI): pav...Empowering NextGen Mobility via Large Action Model Infrastructure (LAMI): pav...
Empowering NextGen Mobility via Large Action Model Infrastructure (LAMI): pav...
Thierry Lestable
 
Securing your Kubernetes cluster_ a step-by-step guide to success !
Securing your Kubernetes cluster_ a step-by-step guide to success !Securing your Kubernetes cluster_ a step-by-step guide to success !
Securing your Kubernetes cluster_ a step-by-step guide to success !
KatiaHIMEUR1
 
Monitoring Java Application Security with JDK Tools and JFR Events
Monitoring Java Application Security with JDK Tools and JFR EventsMonitoring Java Application Security with JDK Tools and JFR Events
Monitoring Java Application Security with JDK Tools and JFR Events
Ana-Maria Mihalceanu
 

Recently uploaded (20)

FIDO Alliance Osaka Seminar: Overview.pdf
FIDO Alliance Osaka Seminar: Overview.pdfFIDO Alliance Osaka Seminar: Overview.pdf
FIDO Alliance Osaka Seminar: Overview.pdf
 
UiPath Test Automation using UiPath Test Suite series, part 4
UiPath Test Automation using UiPath Test Suite series, part 4UiPath Test Automation using UiPath Test Suite series, part 4
UiPath Test Automation using UiPath Test Suite series, part 4
 
Generating a custom Ruby SDK for your web service or Rails API using Smithy
Generating a custom Ruby SDK for your web service or Rails API using SmithyGenerating a custom Ruby SDK for your web service or Rails API using Smithy
Generating a custom Ruby SDK for your web service or Rails API using Smithy
 
Key Trends Shaping the Future of Infrastructure.pdf
Key Trends Shaping the Future of Infrastructure.pdfKey Trends Shaping the Future of Infrastructure.pdf
Key Trends Shaping the Future of Infrastructure.pdf
 
Elevating Tactical DDD Patterns Through Object Calisthenics
Elevating Tactical DDD Patterns Through Object CalisthenicsElevating Tactical DDD Patterns Through Object Calisthenics
Elevating Tactical DDD Patterns Through Object Calisthenics
 
Encryption in Microsoft 365 - ExpertsLive Netherlands 2024
Encryption in Microsoft 365 - ExpertsLive Netherlands 2024Encryption in Microsoft 365 - ExpertsLive Netherlands 2024
Encryption in Microsoft 365 - ExpertsLive Netherlands 2024
 
Leading Change strategies and insights for effective change management pdf 1.pdf
Leading Change strategies and insights for effective change management pdf 1.pdfLeading Change strategies and insights for effective change management pdf 1.pdf
Leading Change strategies and insights for effective change management pdf 1.pdf
 
FIDO Alliance Osaka Seminar: Passkeys at Amazon.pdf
FIDO Alliance Osaka Seminar: Passkeys at Amazon.pdfFIDO Alliance Osaka Seminar: Passkeys at Amazon.pdf
FIDO Alliance Osaka Seminar: Passkeys at Amazon.pdf
 
PCI PIN Basics Webinar from the Controlcase Team
PCI PIN Basics Webinar from the Controlcase TeamPCI PIN Basics Webinar from the Controlcase Team
PCI PIN Basics Webinar from the Controlcase Team
 
State of ICS and IoT Cyber Threat Landscape Report 2024 preview
State of ICS and IoT Cyber Threat Landscape Report 2024 previewState of ICS and IoT Cyber Threat Landscape Report 2024 preview
State of ICS and IoT Cyber Threat Landscape Report 2024 preview
 
GenAISummit 2024 May 28 Sri Ambati Keynote: AGI Belongs to The Community in O...
GenAISummit 2024 May 28 Sri Ambati Keynote: AGI Belongs to The Community in O...GenAISummit 2024 May 28 Sri Ambati Keynote: AGI Belongs to The Community in O...
GenAISummit 2024 May 28 Sri Ambati Keynote: AGI Belongs to The Community in O...
 
Mission to Decommission: Importance of Decommissioning Products to Increase E...
Mission to Decommission: Importance of Decommissioning Products to Increase E...Mission to Decommission: Importance of Decommissioning Products to Increase E...
Mission to Decommission: Importance of Decommissioning Products to Increase E...
 
UiPath Test Automation using UiPath Test Suite series, part 3
UiPath Test Automation using UiPath Test Suite series, part 3UiPath Test Automation using UiPath Test Suite series, part 3
UiPath Test Automation using UiPath Test Suite series, part 3
 
AI for Every Business: Unlocking Your Product's Universal Potential by VP of ...
AI for Every Business: Unlocking Your Product's Universal Potential by VP of ...AI for Every Business: Unlocking Your Product's Universal Potential by VP of ...
AI for Every Business: Unlocking Your Product's Universal Potential by VP of ...
 
FIDO Alliance Osaka Seminar: Passkeys and the Road Ahead.pdf
FIDO Alliance Osaka Seminar: Passkeys and the Road Ahead.pdfFIDO Alliance Osaka Seminar: Passkeys and the Road Ahead.pdf
FIDO Alliance Osaka Seminar: Passkeys and the Road Ahead.pdf
 
Accelerate your Kubernetes clusters with Varnish Caching
Accelerate your Kubernetes clusters with Varnish CachingAccelerate your Kubernetes clusters with Varnish Caching
Accelerate your Kubernetes clusters with Varnish Caching
 
From Siloed Products to Connected Ecosystem: Building a Sustainable and Scala...
From Siloed Products to Connected Ecosystem: Building a Sustainable and Scala...From Siloed Products to Connected Ecosystem: Building a Sustainable and Scala...
From Siloed Products to Connected Ecosystem: Building a Sustainable and Scala...
 
Empowering NextGen Mobility via Large Action Model Infrastructure (LAMI): pav...
Empowering NextGen Mobility via Large Action Model Infrastructure (LAMI): pav...Empowering NextGen Mobility via Large Action Model Infrastructure (LAMI): pav...
Empowering NextGen Mobility via Large Action Model Infrastructure (LAMI): pav...
 
Securing your Kubernetes cluster_ a step-by-step guide to success !
Securing your Kubernetes cluster_ a step-by-step guide to success !Securing your Kubernetes cluster_ a step-by-step guide to success !
Securing your Kubernetes cluster_ a step-by-step guide to success !
 
Monitoring Java Application Security with JDK Tools and JFR Events
Monitoring Java Application Security with JDK Tools and JFR EventsMonitoring Java Application Security with JDK Tools and JFR Events
Monitoring Java Application Security with JDK Tools and JFR Events
 

PhyNexus Desalting Columns

  • 1. PhyNexus Technical Note www.phynexus.com PhyTip® 5K Gel Filtration column for automated high throughput desalting & buffer exchange of functional proteins High Performance: ● Remove >95% of salts with >80% yield of protein ● Retain protein functionality ● <10% CV in volume and concentration ● Ready for downstream assay Automated desalting/buffer exchange of functional proteins: ● Fully automated process with MEA Personal Purification System ● 12 samples desalted/buffer exchanged in ~30 minutes. High throughput format: ● Available in 96 sample format for high throughput processing Introduction For biopharmaceutical companies whose focus is preparing large numbers of potential leads that on antibody and recombinant protein molecules, are ready for functional assays without the need there is an increasing desire to perform more for scale-up. screens of potential leads where the data generated are more physiologically relevant to the In many cases differing elution conditions are issues of potency, toxicity, and other factors. required for various downstream functional These assay formats all require that the antibodies assays. Furthermore, the final purification and recombinant proteins are well purified, product may require an additional preparation enriched and functional. By utilizing high- step to either reduce toxic buffer salts or to performance micro scale functional protein completely exchange buffer conditions. This separations, it is now possible to obtain more latter step can now be achieved through fully physiologically relevant data at the high-content automated desalting and buffer exchange with screening step and thus make the decision-making PhyTip 5K gel filtration columns used in power available at the earliest stages in the conjunction with the MEA Personal Purification discovery process. PhyNexus PhyTip column System. These unique columns allow for high technology has been developed for high- recovery of the functional antibody of interest throughput preparation of antibodies and while removing greater than 95% of salts. recombinant proteins to facilitate the process of For further support call PhyNexus at 408.267.7214 or e-mail support@phynexus.com. For further information on PhyNexus products visit our website at www.phynexus.com Copyright © 2008, PhyNexus, Inc., All Rights Reserved
  • 2. PhyNexus PhyTip 5K Gel Filtration Technical Note Fig 1 PhyTip 5K Gel Filtration Columns The design of the patent pending 5K gel filtration columns (Fig 1) is based upon a unique manufacturing process where pipette tips are filled with gel filtration resin. Thin screens are placed above and below the resin bed that retain the gel filtration media within the column structure, while allowing the passage of liquids. The top frit is a larger liquid interface barrier that helps facilitate the transfer of liquid to the top of the column. PhyTip 5K gel filtration columns retain small molecules while molecules over 5 KDa will pass through the gel filtration media. screens Desalting or Buffer Exchange Process Using the MEA Personal Purification System, a row of either 200µL or Resin bed resin bed PhyTip 5K gel filtration columns are conditioned in 1mL of buffer. After the columns are conditioned, samples are added and processed followed by differing volumes of chaser buffer addition and processing. The samples can be collected in fractions to determine the optimal sample recovery and salt removal conditions. Using the MEA Personal Purification System, each row of 12 samples requires 30 minutes to process while the entire plate of 96 samples can be processed in 2.5 hours. Results The process of desalting or buffer exchange using the PhyTip 5K desalting columns and the MEA Personal Purification System have been carefully optimized to ensure both maximum recovery of the protein of interest and removal of salt. 160 Fig 2A 140 Consistent Volume Recovery 120 Exp 1 vol in uL Most pharmaceutical companies streamline the 100 80 Exp 2 processes of antibody/protein production, 60 Exp 3 purification, and desalting/buffer exchange for 40 cell-based assays. In order to efficiently process 20 0 the samples from production to cell-based assays, 1 2 3 4 5 6 7 8 9 10 11 12 high throughput solutions are desirable. PhyTip columns However, in practice, achieving a true high throughput solution requires a level of precision Fig 2B Chaser Vol E1: (80uL) E2: (80uL) E3: (130uL) not easily achieved. High throughput sample Column1 73.4 70.9 122.6 preparation is not advantageous if subsequent Column2 71.4 77.4 132.6 quantification is required prior to the next assay. Column3 65.9 64.4 112.6 The solution requires consistent mass and Column4 61.8 65.2 115.0 concentration recovery. Column5 61.6 73.8 118.8 Column6 61.9 61.6 106.5 To determine the consistency of volume Column7 60.0 73.6 119.4 Column8 71.4 76.7 120.6 recovery from 200µL resin bed PhyTip gel Column9 67.1 72.6 133.4 filtration columns, 80µL or 130µL of buffer was Column10 61.6 71.6 121.0 loaded on top of 11 or 12 conditioned columns. Column11 64.7 70.7 110.0 Flow through was collected and the volume was Column12 65.4 74.9 measured. In three replicate experiments, Average 65.5 71.1 119.3 recovered volumes varied by less than 10% CV SD 4.5 5.0 8.4 (Fig 2A & 2B). CV 6.9 7.0 7.0 For further support call PhyNexus at 408.267.7214 or e-mail support@phynexus.com. For further information on PhyNexus products visit our website at www.phynexus.com Copyright © 2008, PhyNexus, Inc., All Rights Reserved
  • 3. PhyNexus PhyTip 5K Gel Filtration Technical Note Separation by PhyTip gel filtration column Fig 3 Sample (far left microfuge tube) containing brown myoglobin protein (16.7kDa) and yellow DNP- 1 2 3 4 5 6 7 1 glutamate salt (313Da) was loaded onto a 600uL PhyTip gel filtration column. The same PhyTip column at different steps of desalting is pictured along with the collected flow through. From left: 1) column conditioned by PBS buffer prior to sample loading, 2) column after 200µL sample has entered the resin bed, 3-6) column after 100µL PBS buffer is applied, 7) column after a final chase of 400uL PBS buffer. This example illustrates a typical separation allowing the 2 3 4 5 6 7 user to discard sample flow through (2) to maintain concentrated purifications. Additionally, salt is retained until fraction (6), while most of the protein is released by fraction (4). HPLC chromatogram (at right) of His-Tagged Sample Pre-Desalting Fig 4 ubiquitin at 0.05mg/mL concentration spiked with 250mM imidazole. 300µL samples (red) were applied to 600µL columns. The resulting desalted sample was His-Ubiquitin collected and adjusted to 300µL with water (blue) to compare with the starting sample. Water was injected as a blank (green). The Post-desalting sample shows Sample both recovery of protein and complete removal of Post-Desalting imidazole. Blank Myoglobin recovery and salt removal After columns are conditioned, samples are first added and processed followed by different volumes of chaser buffer addition and processing. The samples can be collected in fractions to determine the maximum sample recovery. In this experiment, we used myoglobin and DNP-glutamate (20µL sample volume) and separated myoglobin from DNP-glutamate using 80µL chaser volume (Table 1) and 200µL resin bed gel filtration columns. As shown in the table below, we were able to recover ~80% of myoglobin and remove ~99.8% of DNP-glutamate. Using the MEA Personal Purification System each row of 12 samples can be separated in about 30 minutes. A full plate of 96 samples takes about 2.5 hours to process. Table 1: A364 A409 Volume pmol Myo mol Salt % prot rec %salt rem Myoglobin input 1.165 20.0 47843.9 Myoglobin sample1 0.205 90.5 38095.5 79.6 Myoglobin sample2 0.200 94.8 38932.2 81.4 DNP-glutamate input 2.440 20.0 70469.3 DNP-glutamate sample1 0.003 88.7 96.1 99.9 DNP-glutamate sample2 0.006 89.3 193.4 99.7 For further support call PhyNexus at 408.267.7214 or e-mail support@phynexus.com. For further information on PhyNexus products visit our website at www.phynexus.com Copyright © 2008, PhyNexus, Inc., All Rights Reserved
  • 4. PhyNexus PhyTip 5K Gel Filtration Technical Note uL/% recov mg/mL Fig 5 IgG separation and recovery 140 IgG was separated from free dye using a 200µL 120 1.2 resin bed gel filtration column. In this experiment, 100 1.0 Vol Rec ( uL) PhyTip gel filtration columns were first conditioned 80 Conc [ mg/ mL] with 800µL of PBS. After conditioning, 40µL of 60 %IgG r ec [2mg/mL] sample was added and processed 40 0.4 followed by 130µL of chaser (PBS) buffer to the 20 0.2 PhyTip gel filtration column to collect and separate 0 1 2 3 4 5 6 IgG from unlabeled dyes. Figure 5 and Table 2 demonstrate that we were able to recover an average of 76% of IgG (Table 2, Fig. 5 red) with an average of 0.5mg/mL concentration (Table 2, Fig. 5 blue) in an average final volume of 121µL (table 2, fig 5 black). As shown in Table 2, the percent IgG recovery, concentration, and final recovered volume had very small CV values. These SD and CV values show the reliability and consistency of the PhyTip gel filtration columns. Table 2 Column Final Volume Concentration Mass Recovered % Protein # [µL] [mg/mL] (mg) Recovered 1 122 0.49 0.060 75 2 119 0.50 0.060 74 3 122 0.50 0.061 76 4 119 0.54 0.064 80 5 122 0.48 0.059 73 6 123 0.51 0.063 78 Ave 121 0.50 0.061 76 SD 2 0.02 0.002 3 CV 1.4 4.1 3.5 4 Conclusion PhyTip 5K gel filtration columns and the MEA Personal Purification System represent a high throughput solution for rapid desalting and buffer exchange. PhyTip 5K gel filtration columns can process 12 samples in 30 minutes compared to the laborious and time consuming dialysis procedure. Using PhyTip 5K gel filtration columns, researchers can save hours while obtaining a high level of performance. Unlike spin columns, PhyTip columns simulate traditional chromatography and can perform fractionation of protein samples. This allows researchers to optimize maximum protein recovery and salt removal in an automated, high throughput manner. PhyTip 5K gel filtration columns can be used in combination with PhyTip purification columns on the MEA Personal Purification System. This allows researchers to combine purification with desalting and buffer exchange. For example, 6-His-tagged proteins can be purified by PhyNexus IMAC PhyTip columns and eluted using high concentrations of imidazole, which can be removed by PhyTip gel filtration columns. These processes allow researchers to perform multiple sample processing steps in a high throughput, walk-away scenario. For further support call PhyNexus at 408.267.7214 or e-mail support@phynexus.com. For further information on PhyNexus products visit our website at www.phynexus.com Copyright © 2008, PhyNexus, Inc., All Rights Reserved